This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (311) HIV/AIDS/STI Prevention and Care (874)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/52565, first published .
Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Authors of this article:

Naokatsu Ando1 Author Orcid Image ;   Daisuke Mizushima1 Author Orcid Image ;   Yosuke Shimizu2 Author Orcid Image ;   Yukari Uemura2 Author Orcid Image ;   Misao Takano1 Author Orcid Image ;   Morika Mitobe3 Author Orcid Image ;   Kai Kobayashi3 Author Orcid Image ;   Hiroaki Kubota3 Author Orcid Image ;   Hirofumi Miyake3 Author Orcid Image ;   Jun Suzuki3 Author Orcid Image ;   Kenji Sadamasu3 Author Orcid Image ;   Takato Nakamoto1 Author Orcid Image ;   Takahiro Aoki1 Author Orcid Image ;   Koji Watanabe1 Author Orcid Image ;   Shinichi Oka1 Author Orcid Image ;   Hiroyuki Gatanaga1 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.